1 OMEPRAZOLE | 130 of 780 | 2730 prescriptions Less than 1% of all prescriptions | 2080 | 1000 patients 16% of all patients | 810 patients 13% of all patients | |
2 DICYCLOMINE HCL | 10 of 330 | 1780 prescriptions Less than 1% of all prescriptions | 1300 | 610 patients 10% of all patients | 500 patients 8% of all patients | |
3 RANITIDINE HCL | 30 of 320 | 1100 prescriptions Less than 1% of all prescriptions | 850 | 290 patients 5% of all patients | < 11 | |
4 SUCRALFATE | 20 of 290 | 1300 prescriptions Less than 1% of all prescriptions | 930 | 650 patients 10% of all patients | 520 patients 8% of all patients | |
5 DEXILANT (DEXLANSOPRAZOLE) | 20 of 270 | 730 prescriptions Less than 1% of all prescriptions | 300 | 190 patients 3% of all patients | < 11 | |
6 PANTOPRAZOLE SODIUM | 280 of 660 | 470 prescriptions Less than 1% of all prescriptions | 310 | 200 patients 3% of all patients | < 11 | |
7 PENTASA (MESALAMINE) | 10 of 100 | 380 prescriptions Less than 1% of all prescriptions | 380 | < 11 | < 11 | |
8 CREON (LIPASE/PROTEASE/AMYLASE) | 30 of 70 | 260 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
9 HUMIRA PEN (ADALIMUMAB) | 20 of 160 | 280 prescriptions Less than 1% of all prescriptions | 280 | < 11 | < 11 | |
10 URSODIOL | 140 of 270 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
11 METOCLOPRAMIDE HCL | 40 of 100 | 190 prescriptions Less than 1% of all prescriptions | | 110 patients 2% of all patients | < 11 | |
12 PREDNISONE | 30 of 140 | 180 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 ESOMEPRAZOLE MAGNESIUM | 90 of 210 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 BUDESONIDE EC (BUDESONIDE) | 100 of 280 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 CHOLESTYRAMINE (CHOLESTYRAMINE (WITH SUGAR)) | 70 of 190 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 ZENPEP (LIPASE/PROTEASE/AMYLASE) | 30 of 60 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 IMIPRAMINE HCL | 10 of 20 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
18 SPIRONOLACTONE | 80 of 160 | 150 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
19 PHENOBARBITAL | 10 | 140 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
20 SUPREP (SODIUM, POTASSIUM,MAG SULFATES) | 20 of 320 | 2240 prescriptions Less than 1% of all prescriptions | 1870 | 2220 patients 35% of all patients | 1850 patients 30% of all patients | |
21 BALSALAZIDE DISODIUM | 110 of 120 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
22 TRULANCE (PLECANATIDE) | 10 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 VIREAD (TENOFOVIR DISOPROXIL FUMARATE) | 10 of 20 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
24 ASACOL HD (MESALAMINE) | 10 of 20 | 120 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
25 PROTONIX (PANTOPRAZOLE SODIUM) | 10 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |
26 ONDANSETRON ODT (ONDANSETRON) | 50 of 140 | 160 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
27 GAVILYTE-G (PEG3350/SOD SULF,BICARB,CL/KCL) | 90 of 270 | 820 prescriptions Less than 1% of all prescriptions | | 790 patients 13% of all patients | < 11 | |
28 METRONIDAZOLE | 70 of 110 | 140 prescriptions Less than 1% of all prescriptions | | 130 patients 2% of all patients | < 11 | A |
29 FLUCONAZOLE | 30 of 50 | 120 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
30 PEG 3350-ELECTROLYTE (PEG3350/SOD SULF,BICARB,CL/KCL) | 190 of 280 | 170 prescriptions Less than 1% of all prescriptions | | 170 patients 3% of all patients | < 11 | |
31 PEG-3350 AND ELECTROLYTES (PEG3350/SOD SULF,BICARB,CL/KCL) | 80 of 90 | 120 prescriptions Less than 1% of all prescriptions | | 120 patients 2% of all patients | < 11 | |